Krystal Biotech
KRYS
KRYS
234 hedge funds and large institutions have $4.49B invested in Krystal Biotech in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 62 increasing their positions, 83 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
20% less call options, than puts
Call options by funds: $112M | Put options by funds: $140M
25% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 83
Holders
234
Holding in Top 10
5
Calls
$112M
Puts
$140M
Top Buyers
| 1 | +$331M | |
| 2 | +$41.1M | |
| 3 | +$36.7M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18.7M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$17.6M |
Top Sellers
| 1 | -$74.8M | |
| 2 | -$52.1M | |
| 3 | -$40M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$36.7M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$27.3M |